Tumor regression and autoimmunity in cytotoxic T lymphocyte-associated antigen 4 blockade-treated patients

Ann Surg Oncol. 2005 Dec;12(12):957-9. doi: 10.1245/ASO.2005.08.917. Epub 2005 Oct 26.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD
  • Antigens, Differentiation / therapeutic use*
  • CTLA-4 Antigen
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Immunotherapy / methods*
  • Interleukin-2 / therapeutic use*
  • Melanoma / drug therapy*
  • Skin Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunosuppressive Agents
  • Interleukin-2